External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
Eleni Karatza(National and Kapodistrian University of Athens), Daniel González(University of North Carolina at Chapel Hill), Chi D. Hornik, William J. Muller(Lurie Children's Hospital), Amira Al‐Uzri(Oregon Health & Science University), Stephen J. Balevic(Duke University), Laura P. James(University of Arkansas for Medical Sciences), Samit Ganguly(University of North Carolina at Chapel Hill)
Cited by 4
Related Papers
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
|Clinical Infectious Diseases|2022|201